The U.K. government wants to boost the local life sciences industry, and it hopes to entice American venture capital firms to ...

The New York Times once called John Lamattina, then Pfizer head of R&D, “Dr. Optimistic.” He’s not so optimistic now.

Two government officials told STAT that the White House has been involved in final decisions about the FDA's new priority ...

Every major pharmaceutical breakthrough in the past 40 years started with taxpayer-funded basic research: mRNA vaccines, ...

Republicans in Congress are making a renewed push before the end of the year to pass major federal restrictions to ...

The award is in response to an “unsolicited proposal,” according to documents in the Federal Register. The University of ...

President Trump weighs in on a debate between hard-liners on marijuana and those who want more research on its medical uses.

The Trump administration intends to make its most forceful attempt yet at restricting gender-affirming care for transgender ...

A Lilly investigational obesity pill largely helped patients maintain their weight loss after they switched from injectable ...

A Trump administration change to how NIH awards grants has sharply reduced early-stage investigators’ odds of securing ...

Is the biotech industry truly out of its slump? This week on "The Readout LOUD," a biotech year in review and a look ahead to ...

OnPoint, the nation's first supervised drug consumption site, vows to continue its approach to harm reduction.